Acquisition by Tajinder Vohra of 5492 shares of Revvity at 81.29 subject to Rule 16b-3
RVTY Stock | 116.42 0.18 0.15% |
Slightly above 61% of Revvity's investor base is looking to short. The analysis of overall sentiment of trading Revvity stock suggests that many investors are alarmed at this time. Revvity's investing sentiment can be driven by a variety of factors including economic data, Revvity's earnings reports, geopolitical events, and overall market trends.
Revvity |
Filed transaction by Revvity Officer: Please See Remarks. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at finance.yahoo.com
Revvity Fundamental Analysis
We analyze Revvity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Revvity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Revvity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
Revvity is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Revvity Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Revvity stock to make a market-neutral strategy. Peer analysis of Revvity could also be used in its relative valuation, which is a method of valuing Revvity by comparing valuation metrics with similar companies.
Peers
Revvity Related Equities
MEDP | Medpace Holdings | 2.24 | ||||
IDXX | IDEXX Laboratories | 1.19 | ||||
IQV | IQVIA Holdings | 0.82 | ||||
QGEN | Qiagen NV | 0.71 | ||||
NEOG | Neogen | 0.69 | ||||
A | Agilent Technologies | 0.30 | ||||
LH | Laboratory | 0.34 | ||||
MTD | Mettler Toledo | 0.68 | ||||
WAT | Waters | 0.75 | ||||
CRL | Charles River | 0.97 | ||||
TWST | Twist Bioscience | 1.10 | ||||
ICLR | ICON PLC | 1.46 | ||||
ACRS | Aclaris Therapeutics | 1.60 |
Additional Tools for Revvity Stock Analysis
When running Revvity's price analysis, check to measure Revvity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revvity is operating at the current time. Most of Revvity's value examination focuses on studying past and present price action to predict the probability of Revvity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revvity's price. Additionally, you may evaluate how the addition of Revvity to your portfolios can decrease your overall portfolio volatility.